Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-01-30FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by ROERIG.
-
FDA approval · 2009-01-30FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE from Apotex Corp.
-
FDA approval · 2009-01-30FDA Approved: PAXIL — Supplemental Application (Apotex Corp)
FDA approved a supplemental application from Apotex Corp for Paxil (paroxetine hydrochloride), authorizing a generic version under the exist…
-
FDA approval · 2009-01-30FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approves a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Escitalopram in Schizophrenia in OCD- Open Label Study [Phase 4]
Open-label Phase 4 trial evaluating escitalopram in schizophrenia with comorbid obsessive-compulsive disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Tolerability And Efficacy Of High Dose Escitalopram In The Treatment Of Patients Suffering From Schizophrenia And Obsessive-Compulsive Disorder (OCD) - An Open Label Study [Phase 4]
An open-label Phase 4 trial evaluating tolerability and efficacy of high-dose escitalopram in patients with obsessive-compulsive disorder an…
-
CLINICAL_TRIALS trial_result · 2008-12-08Clinical Trial Update: Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety [Phase 4]
Phase 4 clinical trial update reporting the completion of a study evaluating Seroquel SR (quetiapine) for alcohol use disorder with comorbid…
-
CLINICAL_TRIALS research · 2008-11-13Clinical Trial Update: Mechanisms of Fronto-Subcortical Dysfunction: Comparing PD and OCD
This clinical trial update discusses research into the neural mechanisms of fronto-subcortical dysfunction in Parkinson's disease and obsess…
-
FDA approval · 2008-10-31FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for paroxetine hydrochloride (paroxetine HCl), confirming continued approval for the gen…
-
FDA approval · 2008-10-31FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved an original generic application for sertraline hydrochloride by Rising Pharma Holdings, Inc., allowing a generic version of…
-
FDA approval · 2008-10-22FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., indicating a modification to the product's a…
-
FDA approval · 2008-09-25FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for Fluoxetine hydrochloride from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS trial_result · 2008-09-04Clinical Trial Update: Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD) [Phase 4]
Phase 4 cost-effectiveness study assessing the addition of web-based cognitive-behavioral therapy to Luvox CR for obsessive-compulsive disor…
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental ANDA for Fluoxetine by Teva Pharmaceuticals USA, Inc., authorizing a generic version of fluoxetine. The action f…
-
CLINICAL_TRIALS trial_result · 2008-07-29Clinical Trial Update: Unilateral Deep Brain Stimulation (DBS) of the Nucleus (Nucl.) Accumbens (Acc.) in Patients With Treatment Resistant Obsessive Compulsive Disorder (OCD) [NA]
A completed clinical trial evaluating unilateral deep brain stimulation of the nucleus accumbens for treatment-resistant obsessive-compulsiv…
-
FDA approval · 2008-07-16FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves a supplemental abbreviated new drug application (ANDA) for sertraline from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals …
-
FDA approval · 2008-07-02FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for sertraline hydrochloride (generic sertraline), authorizing the a…
-
CLINICAL_TRIALS other · 2008-07-02Clinical Trial Update: Treatment Youth With Obsessive-Compulsive Disorder [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating treatment for youth with obsessive-compulsive disorder; the current …
-
FDA approval · 2008-06-25FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for sertraline hydrochloride manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2008-05-29FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. under anANDA, confirming r…
-
FDA approval · 2008-05-20FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for paroxetine hydrochloride/paroxetine from Zydus Lifesciences Limited, authorizing a generic parox…
-
FDA approval · 2008-04-17FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine by Teva Pharmaceuticals USA, Inc. The approval updates the product labeling and/o…
-
FDA approval · 2008-03-21FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2008-03-13FDA Approved: PAROXETINE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic paroxetine product (paroxetine hydrochloride hemihydrate) from Mylan Pharmaceuticals Inc. under an original ANDA.